FIELD: medicine.
SUBSTANCE: invention relates to medicine, specifically to ophthalmology, and is intended for use in the treatment, alleviation or prevention of optic nerve damage. In the treatment, alleviation or prevention of optic nerve damage, a combination comprising at least 5 g of eicosapentaenoic acid and docosahexaenoic acid at a mass ratio of EPA:DHA from 1:1 to 5:1 is used.
EFFECT: use of the invention makes it possible to improve visual acuity and field of vision in patients with optic nerve damage.
15 cl, 1 tbl, 7 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF OMEGA FATTY ACIDS FOR TREATING DISEASE | 2012 |
|
RU2589703C2 |
| BARRIER INTEGRITY IMPROVEMENT IN HIV PATIENTS | 2005 |
|
RU2429718C2 |
| NEUROPROTECTIVE AND RETINOPROTECTIVE AGENT N-ACETYL-DL-LEUCINE | 2011 |
|
RU2598339C2 |
| LIQUID ENTERAL NUTRIENT COMPOSITION SUITABLE FOR ENTERAL FEEDING, MINIMISING UPPER AND LOWER GASTROINTESTINAL COMPLICATIONS | 2010 |
|
RU2516782C2 |
| NUTRICEUTICAL OPHTHALMOLOGICAL COMPOSITION FOR TREATMENT OF RETINAL PATHOLOGIES WITH A NEOVASCULAR COMPONENT | 2019 |
|
RU2806096C2 |
| NUTRITIONAL COMPOSITION FOR IMPROVING CEREBRAL FUNCTION IN PHENYLKETONURIA | 2014 |
|
RU2690660C2 |
| ENRICHED OMEGA-3 FISH PARENTERAL NUTRITIOUS EMULSIONS OF OIL-IN-WATER TYPE | 2010 |
|
RU2555771C2 |
| IMPROVEMENT OF MEMORY IN PATIENTS WITH 24-26 POINTS BY MENTAL STATE MINI-EXAMINATION | 2008 |
|
RU2529815C2 |
| COMPOSITION OF LACTOSE-FREE MIX FOR DIET NUTRITION OF INFANTS WITH GALACTOSEMIA | 2009 |
|
RU2402928C1 |
| METHOD FOR IMPROVING FUNCTIONAL SYNAPTIC CONNECTIVITY | 2013 |
|
RU2667968C2 |
